The Business Of CNS with Acumen's Jim Doherty, Ph.D.
Business Of Biotech
Intro
This chapter explores the speaker's career in neuroscience, highlighting the critical demand for new treatments for CNS disorders like Alzheimer's and mental health issues. It also covers the evolution of therapeutic modalities, including genetic and cell-based therapies, in the biotech field.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
